Validated screening tools can help, but Friedman said several straightforward questions can also be incorporated into routine visits. He asks patients about prolonged stiffness at rest that improves ...
Joint pain is frequently dismissed as an inevitable consequence of aging; however, it may point to significant underlying ...
Five months into the U.S. launch of Bristol Myers Squibb’s (BMS) Sotyktu (deucravacitinib) for psoriatic arthritis (PsA), rheumatologists are increasingly adding the oral TYK2 inhibitor to their ...
KARACHI: Early diagnosis, timely treatment and greater public awareness are essential to preventing permanent joint damage ...
NPF begins a global push to unearth and address the remaining milestones on the path to a cure for psoriasis and ...
Dr. Bunick introduces the panel's second case: a 72-year-old retired school administrator with plaque psoriasis diagnosed at ...
Researchers compared the national FORWARD psoriasis registry against a single academic institution's electronic medical ...
Arthritis doesn't have to control your life. With the right orthopaedic care, you can reduce pain, protect your joints, and stay active in the activities you love. Whether it's walking the beach, ...
Johnson & Johnson (NYSE: JNJ) today announced that TREMFYA® (guselkumab) met the primary and major secondary endpoints demonstrating both improvement in axial symptoms and reduction in inflammation by ...
Anti-obesity pills and a triple agonist, retatrutide, are the highly anticipated innovations expected in the near future for ...
Clinical Trials Arena on MSN
Lilly reports Phase IIIb data on Taltz and Zepbound combination
By week 36, dual therapy shifted 482 proteins and 467 genes, compared with 140 proteins and 16 genes.
The 6-minute walk test is an effective screening tool for identifying impaired cardiorespiratory fitness in patients with psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results